The PMICR, hosted by Aurora Biomed, is in its 17th year and has evolved into one of the premier conferences for drug discovery, genomics and ion channel research. PMICR has a healthy mix of international speakers from academia and industry. This fuels a diverse, thought-provoking conference that allows academic and industry researchers to share knowledge, exchange ideas and establish fruitful partnerships. The conference is designed to maximize networking opportunities, with social events providing a relaxed atmosphere.
This year’s conference has sessions addressing; key methodology & technologies for precision medicine, ion channels as pain targets and CiPA’s Impact on Drug Discovery. There will also be specific disease tract sessions including Cancer (diagnosis and treatment), Epilepsy and neurodegenerative diseases.
For more information on the conference and to register please visit the official conference website.
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.
Pick up your copy of this essential resource.